Evidence map›Paper›PMID 30927002›Full record

ArticleNucleic acids research2019

PIXUL-ChIP: integrated high-throughput sample preparation and analytical platform for epigenetic studies.

Karol Bomsztyk, Daniel Mar, Yuliang Wang, Oleg Denisenko, Carol Ware, Christian D Frazar, Adam Blattler, Adam D Maxwell, Brian E MacConaghy, Thomas J Matula

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Analysis of DNA Methylation in Gliomas: Assessment of Preanalytical Variables.Laboratory investigation; a journal of technical methods and pathology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. [Development of a high intensity focused ultrasound device for bio-samples preparation].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Karol BomsztykUW Medicine South Lake Union, University of Washington, Seattle, WA 98109, USA.
Daniel MarUW Medicine South Lake Union, University of Washington, Seattle, WA 98109, USA.
Yuliang WangUW Medicine South Lake Union, University of Washington, Seattle, WA 98109, USA.
Oleg DenisenkoUW Medicine South Lake Union, University of Washington, Seattle, WA 98109, USA.
Carol WareInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.
Christian D FrazarDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Adam BlattlerActive Motif, Carlsbad, CA 92008, USA.
Adam D MaxwellDepartment of Urology, University of Washington School of Medicine, Seattle, WA 98195, USA.
Brian E MacConaghyCenter for Industrial and Medical Ultrasound, Applied Physics Laboratory, University of Washington, Seattle, WA 98195, USA.
Thomas J MatulaCenter for Industrial and Medical Ultrasound, Applied Physics Laboratory, University of Washington, Seattle, WA 98195, USA.
University of Washington · USUniversity of Washington Applied Physics Laboratory · USActive Motif (United States) · USUnion University · US

Funding

A high-throughput sample preparation platform for genomic and epigenetic analysisR44GM122097 · NIGMS · MATCHSTICK TECHNOLOGIES, INC. · PI DARLINGTON, GREG · 2017 to 2018
$1.5M
Next generation technology to detect epigenetic alterations in human tissuesR33CA191135 · NCI · UNIVERSITY OF WASHINGTON · PI BOMSZTYK, KAROL · 2015 to 2017
$1.3M
Transcriptional and epigenetic control of angiogenic genes in sepsis-induced acute kidney injury.R01DK103849 · NIDDK · UNIVERSITY OF WASHINGTON · PI BOMSZTYK, KAROL · 2016 to 2018
$790k
Integrated microplate platform for epigenetic analysisR21GM111439 · NIGMS · UNIVERSITY OF WASHINGTON · PI BOMSZTYK, KAROL · 2014 to 2016
$601k
NCI NIH HHS R33 CA191135NIDDK NIH HHS R01 DK103849NIGMS NIH HHS R21 GM111439NIGMS NIH HHS R44 GM122097
6 · The paper itself

Abstract

Chromatin immunoprecipitation (ChIP) is the most widely used approach for identification of genome-associated proteins and their modifications. We have previously introduced a microplate-based ChIP platform, Matrix ChIP, where the entire ChIP procedure is done on the same plate without sample transfers. Compared to conventional ChIP protocols, the Matrix ChIP assay is faster and has increased throughput. However, even with microplate ChIP assays, sample preparation and chromatin fragmentation (which is required to map genomic locations) remains a major bottleneck. We have developed a novel technology (termed 'PIXUL') utilizing an array of ultrasound transducers for simultaneous shearing of samples in standard 96-well microplates. We integrated PIXUL with Matrix ChIP ('PIXUL-ChIP'), that allows for fast, reproducible, low-cost and high-throughput sample preparation and ChIP analysis of 96 samples (cell culture or tissues) in one day. Further, we demonstrated that chromatin prepared using PIXUL can be used in an existing ChIP-seq workflow. Thus, the high-throughput capacity of PIXUL-ChIP provides the means to carry out ChIP-qPCR or ChIP-seq experiments involving dozens of samples. Given the complexity of epigenetic processes, the use of PIXUL-ChIP will advance our understanding of these processes in health and disease, as well as facilitate screening of epigenetic drugs.

Indexed as

Epigenesis, GeneticAnimalsCell LineChromatinChromatin ImmunoprecipitationDNAEmbryonic Stem CellsFemaleHumansMaleMice, Inbred C57BLRNA Polymerase IIUltrasonic WavesChromatinDNARNA Polymerase II

Identifiers

PMID30927002
PMCPMC6614803
OpenAlexW2927296120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.